Journal of Chest Surgery

  • 제50권2호
  • /
  • Pages.86-93
  • /
  • 2017
  • /
  • 2765-1606(pISSN)
  • /
  • 2765-1614(eISSN)
대한심장혈관흉부외과학회 (The Korean Society for Thoracic and Cardiovascular Surgery)
권호 표지
DOI QR코드

DOI QR Code

Impact of Lifestyle Diseases on Postoperative Complications and Survival in Elderly Patients with Stage I Non-Small Cell Lung Cancer

  • Jeong, Sang Seok (Department of Thoracic and Cardiovascular Surgery, Dong-A University College of Medicine) ;
  • Choi, Pil Jo (Department of Thoracic and Cardiovascular Surgery, Dong-A University College of Medicine) ;
  • Yi, Jung Hoon (Department of Thoracic and Cardiovascular Surgery, Dong-A University College of Medicine) ;
  • Yoon, Sung Sil (Department of Thoracic and Cardiovascular Surgery, Dong-A University College of Medicine)
  • 투고 : 2016.09.30
  • 심사 : 2016.12.21
  • 발행 : 2017.04.05
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Background: The influence of lifestyle diseases on postoperative complications and long-term survival in patients with non-small cell lung cancer (NSCLC) is unclear. The aim of this study was to determine whether lifestyle diseases were significant risk factors of perioperative and long-term surgical outcomes in elderly patients with stage I NSCLC. Methods: Between December 1995 and November 2013, 110 patients aged 65 years or older who underwent surgical resection of stage I NSCLC at Dong-A University Hospital were retrospectively studied. We assessed the presence of the following lifestyle diseases as risk factors for postoperative complications and long-term mortality: diabetes, hypertension, chronic obstructive pulmonary disease, stroke, and ischemic heart disease. Results: The mean age of the patients was 71 years (range, 65 to 82 years). Forty-six patients (41.8%) had hypertension, making it the most common lifestyle disease, followed by diabetes (n=23, 20.9%). The in-hospital mortality rate was 0.9% (n=1). The 3-year and 5-year survival rates were 78% and 64%, respectively. Postoperative complications developed in 32 patients (29.1%), including 7 (6.4%) with prolonged air leakage, 6 (5.5%) with atrial fibrillation, 5 (4.5%) with delirium and atelectasis, and 3 (2.7%) with acute kidney injury and pneumonia. Univariate and multivariate analyses showed that the presence of a lifestyle disease was the only independent risk factor for postoperative complications. In survival analysis, univariate analysis showed that age, smoking, body mass index, extent of resection, and pathologic stage were associated with impaired survival. Multivariate analysis revealed that resection type (hazard ratio [HR], 2.20; 95% confidence interval [CI], 1.08 to 4.49; p=0.030) and pathologic stage (HR, 1.89; 95% CI, 1.02 to 3.49; p=0.043) had independent adverse impacts on survival. Conclusion: This study demonstrated that the presence of a lifestyle disease was a significant prognostic factor for postoperative complications, but not of survival, in elderly patients with stage I NSCLC. Therefore, postoperative complications may be influenced by the presence of a lifestyle disease.

키워드

참고문헌

  1. Senapati S, Bharti N, Bhattacharya A. Modern lifestyle diseases: chronic diseases, awareness and prevention. Int J Curr Res Acad Rev 2015;3:215-23.
  2. World Health Organization. Global status report on noncommunicable diseases 2014 [Internet]. Geneva: World Health Organization; 2014 [cited 2016 Sep 28]. Available from: http://apps.who.int/iris/bitstream/10665/148114/1/9789241564854_eng.pdf?ua=1.
  3. Oh YH. The health status of older Koreans and policy considerations. Health Welf Policy Forum 2015;223:29-39.
  4. Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 2008;83: 584-94. https://doi.org/10.1016/S0025-6196(11)60735-0
  5. Okada M, Koike T, Higashiyama M, Yamato Y, Kodama K, Tsubota N. Radical sublobar resection for small-sized non-small cell lung cancer: a multicenter study. J Thorac Cardiovasc Surg 2006;132:769-75. https://doi.org/10.1016/j.jtcvs.2006.02.063
  6. Janssen-Heijnen ML, Schipper RM, Razenberg PP, Crommelin MA, Coebergh JW. Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population-based study. Lung Cancer 1998;21:105-13. https://doi.org/10.1016/S0169-5002(98)00039-7
  7. Gajra A. Assessment of comorbidity in lung cancer: how, why, and in whom? J Geriatr Oncol 2016;7:64-7. https://doi.org/10.1016/j.jgo.2016.02.003
  8. Pei G, Zhou S, Han Y, Liu Z, Xu S. Risk factors for postoperative complications after lung resection for non-small cell lung cancer in elderly patients at a single institution in China. J Thorac Dis 2014;6:1230-8.
  9. Okami J, Higashiyama M, Asamura H, et al. Pulmonary resection in patients aged 80 years or over with clinical stage I non-small cell lung cancer: prognostic factors for overall survival and risk factors for postoperative complications. J Thorac Oncol 2009;4:1247-53. https://doi.org/10.1097/JTO.0b013e3181ae285d
  10. Shiono S, Abiko M, Sato T. Postoperative complications in elderly patients after lung cancer surgery. Interact Cardiovasc Thorac Surg 2013;16:819-23. https://doi.org/10.1093/icvts/ivt034
  11. McSorley ST, Watt DG, Horgan PG, McMillan DC. Postoperative systemic inflammatory response, complication severity, and survival following surgery for colorectal cancer. Ann Surg Oncol 2016;23:2832-40. https://doi.org/10.1245/s10434-016-5204-5
  12. Tammemagi CM, Neslund-Dudas C, Simoff M, Kvale P. Impact of comorbidity on lung cancer survival. Int J Cancer 2003;103:792-802. https://doi.org/10.1002/ijc.10882
  13. Piccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel EL Jr. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 2004;291:2441-7. https://doi.org/10.1001/jama.291.20.2441
  14. Battafarano RJ, Piccirillo JF, Meyers BF, et al. Impact of comorbidity on survival after surgical resection in patients with stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 2002;123:280-7. https://doi.org/10.1067/mtc.2002.119338
  15. Moro-Sibilot D, Aubert A, Diab S, et al. Comorbidities and Charlson score in resected stage I nonsmall cell lung cancer. Eur Respir J 2005;26:480-6. https://doi.org/10.1183/09031936.05.00146004
  16. Birim O, Kappetein AP, Bogers AJ. Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer. Eur J Cardiothorac Surg 2005;28:759-62. https://doi.org/10.1016/j.ejcts.2005.06.046
  17. Islam KM, Jiang X, Anggondowati T, Lin G, Ganti AK. Comorbidity and survival in lung cancer patients. Cancer Epidemiol Biomarkers Prev 2015;24:1079-85. https://doi.org/10.1158/1055-9965.EPI-15-0036

피인용 문헌

  1. Trends in major upper abdominal surgery for cancer in octogenarians: Has there been a change in patient selection? vol.124, pp.1, 2017, https://doi.org/10.1002/cncr.30977
  2. Cardiovascular mortality trends in non-Hodgkin’s lymphoma: a population-based cohort study vol.18, pp.1, 2017, https://doi.org/10.1080/14737140.2018.1409626
  3. The preoperative HbA1c level is an independent prognostic factor for the postoperative survival after resection of non-small cell lung cancer in elderly patients vol.48, pp.5, 2018, https://doi.org/10.1007/s00595-017-1612-9
  4. Diabetes mellitus and survival of non‐small cell lung cancer patients after surgery: A comprehensive systematic review and meta‐analysis vol.10, pp.3, 2019, https://doi.org/10.1111/1759-7714.12985
  5. Personalized Prognosis of Oncosurgical Patients Using Standard Tool Microsoft Access vol.1769, pp.None, 2021, https://doi.org/10.1088/1742-6596/1769/1/012001
  6. Factors affecting the efficacy and safety of docetaxel combined with platinum in the treatment of advanced non-small cell lung cancer vol.14, pp.10, 2017, https://doi.org/10.1080/17512433.2021.1976638
  7. Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a Monoclonal Antibody (SCTA01) Targeting SARS-CoV-2 in Healthy Adults: a Randomized, Double-Blind, Placebo-Controlled, Phase I Study vol.65, pp.11, 2017, https://doi.org/10.1128/aac.01063-21